Christine Pyne
Primary Care · Chambersburg, PANPI 1114333713
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $639, 9.5 times the $67 reported in 2021.
Across 130 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$383
- AbbVie$287
- GSK$231
- Lilly USA, LLC$230
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$215
- Amgen$213
- plus $798 from 14 others
What the payments were for
- Food & beverage$2,356100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 20 | $383 |
| AbbVie | 15 | $287 |
| GSK | 12 | $231 |
| Lilly USA, LLC | 13 | $230 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $215 |
| Amgen | 12 | $213 |
| Pfizer | 12 | $208 |
| AstraZeneca | 8 | $132 |
| Exact Sciences | 3 | $85 |
| Phathom Pharmaceuticals, Inc. | 5 | $68 |
| Dexcom, Inc. | 3 | $57 |
| Johnson & Johnson | 3 | $52 |
| Cequr Corporation | 2 | $47 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Novartis | 1 | $21 |
| Insightec,inc | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
How this compares
$2,356 in reported general payments places this provider in the 85th percentile of 300 primary care providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 43 | $78,743 |
| JardianceEmpagliflozin | 79 | $66,781 |
| OzempicSemaglutide | 40 | $65,928 |
| MounjaroTirzepatide | 36 | $52,177 |
| EliquisApixaban | 89 | $51,078 |
| JanuviaSitagliptin Phosphate | 53 | $22,901 |
| XareltoRivaroxaban | 19 | $21,853 |
| RybelsusSemaglutide | 11 | $20,518 |
| FarxigaDapagliflozin Propanediol | 12 | $20,305 |
| OxycontinOxycodone Hcl | 25 | $17,209 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $13,023 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 31 | $7,613 |
| Atorvastatin Calcium | 276 | $3,079 |
| Diclofenac Sodium | 28 | $2,977 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 80 | $2,605 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $230 | $130,92079 claims |
| Novo NordiskOzempic, Rybelsus | $383 | $86,44651 claims |
| PfizerEliquis | $208 | $51,07889 claims |
| Johnson & JohnsonXarelto | $52 | $21,85319 claims |
| AstraZenecaFarxiga | $132 | $20,30512 claims |
| GSKTrelegy Ellipta | $231 | $13,02321 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 300 primary care providers in Pennsylvania.
Other primary care in Chambersburg
- Kersten ReiderMount Penn$121K
- Teresa GiamboyPhiladelphia$21K
- Nicole IlgenfritzBethel Park$18K
- Galyna VorokhibPhiladelphia$12K
- Melissa BeansWarrington$12K
- Mollie McGuireJohnstown$11K
- Andrea MauriceNew Cumberland$11K
- Kendell SoglieroSmithfield$9K
- Minjung RegerDoylestown$9K
- Mackenzie HouserMedia$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.